1. Home
  2. Companies
  3. Aytu BioScience
  4. Financial Statements
  5. Income Statement
  6. Operating Expenses
Aytu BioScience logo
Aytu BioScience AYTU
$ 2.15 -1.83%

Quarterly report 2026-Q3
added 05-13-2026

report update icon

Aytu BioScience Operating Expenses 2011-2026 | AYTU

Annual Operating Expenses Aytu BioScience

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005
53.7 M 50.6 M 83.7 M 162 M 88.1 M 41 M 22 M 19.5 M 20.7 M 15.8 M 7.81 M 6.41 M 54.2 K 58.1 K 134 K - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
162 M 54.2 K 38.1 M

Quarterly Operating Expenses Aytu BioScience

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
11.7 M 11.6 M 10.7 M 11.6 M 10.7 M - 10.4 M 12.5 M 12.9 M - 12 M 11.5 M 13.9 M - 21.3 M 24.2 M 19.8 M 43.8 M 66.1 M 23.6 M 40.2 M 63.7 M 25.2 M 14.5 M 13 M - 17.1 M 8.14 M 6.18 M 14.3 M 6.18 M 6.35 M 4.85 M 6.35 M 4.85 M 5.05 M 5.43 M 5.05 M 5.43 M 4.99 M 6.66 M 4.99 M 6.66 M 3.48 M 2.65 M 3.48 M 1.83 M 1.61 M - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
66.1 M 1.61 M 14 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer Operating Expenses Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
 		15.3 M - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
 		432 M - 2.43 % $ 254 M germanyGermany
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		6.79 M - 1.35 % $ 17.8 M chinaChina
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
 		137 M - - $ 2.02 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
 		24.2 M - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
 		1.49 B - - $ 866 M chinaChina
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
 		226 M - - $ 2.18 B usaUSA
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		2.66 B - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
 		78.3 M - 2.54 % $ 160 B franceFrance
Alpine Immune Sciences Alpine Immune Sciences
ALPN
 		103 M - - $ 2.17 B usaUSA
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited
ASLN
 		55.7 M - -14.27 % $ 1.7 M singaporeSingapore
AstraZeneca PLC AstraZeneca PLC
AZN
 		17.6 B - - $ 96.9 B britainBritain
CureVac N.V. CureVac N.V.
CVAC
 		88.9 M - - $ 867 M germanyGermany
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		8.22 M - -1.52 % $ 24.7 M usaUSA
Athira Pharma Athira Pharma
ATHA
 		18.7 M - - $ 269 M usaUSA
BiondVax Pharmaceuticals Ltd. BiondVax Pharmaceuticals Ltd.
BVXV
 		78.4 M - 0.74 % $ 768 M israelIsrael
Abcam plc Abcam plc
ABCM
 		170 M - - $ 4.9 B britainBritain
Galera Therapeutics Galera Therapeutics
GRTX
 		70.6 M - -32.59 % $ 7.61 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		4.78 M - -18.52 % $ 27.3 M britainBritain
Affimed N.V. Affimed N.V.
AFMD
 		54 M - -34.95 % $ 21.5 M germanyGermany
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
 		668 M $ 49.8 -0.86 % $ 4.48 B schweizSchweiz
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		629 M - - - russiaRussia
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
 		61.5 M - - $ 231 M usaUSA
Celyad Oncology SA Celyad Oncology SA
CYAD
 		26.2 M - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
 		152 M - -7.31 % $ 87 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
 		58.1 M $ 31.27 4.37 % $ 2.08 B usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
 		162 M - - $ 344 M usaUSA
IMV IMV
IMV
 		35.1 M - - $ 13.1 M canadaCanada
Akero Therapeutics Akero Therapeutics
AKRO
 		80.2 M - - $ 3.67 B usaUSA
Akouos Akouos
AKUS
 		86.8 M - 0.23 % $ 488 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		29.8 M - - $ 7.46 M israelIsrael
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		9.17 M - -4.36 % $ 27 M usaUSA
Freeline Therapeutics Holdings plc Freeline Therapeutics Holdings plc
FRLN
 		98.4 M - - $ 384 M britainBritain
Gracell Biotechnologies Gracell Biotechnologies
GRCL
 		214 M - - $ 3.37 B chinaChina
Anika Therapeutics Anika Therapeutics
ANIK
 		51.6 M $ 14.72 - $ 211 M usaUSA
Advaxis Advaxis
ADXS
 		19.6 M - -9.65 % $ 45.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
 		13.3 M - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		210 M - - $ 1.01 B usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
 		15 M $ 0.67 -6.8 % $ 30.6 M israelIsrael
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		66.5 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		179 M - 1.93 % $ 17.4 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		10.4 M $ 2.84 -0.35 % $ 4.68 M israelIsrael
Forte Biosciences Forte Biosciences
FBRX
 		70.7 M $ 17.56 0.92 % $ 227 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
 		343 M $ 3.15 - $ 655 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
 		24.7 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
 		62.6 M - -39.0 % $ 4.57 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
 		163 M - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
 		46.2 M - 4.14 % $ 49.1 M usaUSA
Allakos Allakos
ALLK
 		122 M - - $ 28.6 M usaUSA